mhurhangee/ep-ind-claims huggingface dataset:
Connector assembly (100; 100') comprising a connector housing (300; 300'), a secondary locking member (200; 200') and at least one safety spring bar (400; 400'), whereby the secondary locking member (200; 200') and the safety spring bar (400; 400') are mounted to the connector housing (300; 300') and the secondary locking member (200; 200') is movable between a first and a second position and the safety spring bar (400; 400') is adapted to lock the secondary locking member (200; 200') in its second position, characterized in that the safety spring bar (400; 400') has at least one free end (403; 403'), which is movable in one direction essentially parallel to an insertion direction of the secondary locking member (200,200') when said secondary locking member (200,200') is moved from its first position towards its second position, and in one direction sideways to said insertion direction, the secondary locking member (200; 200') comprises at least one deflection surface adapted to engage the safety spring bar (400; 400') when the secondary locking member (200; 200') is moved in said insertion direction from its first position towards its second position, whereby upon movement of the secondary locking member (200; 200') the safety spring bar (400; 400') is deflected essentially in the insertion direction, thereby urging the secondary locking member (200; 200') towards its first position, the connector housing (300; 300') comprises a releasing portion, whereby movement of the free end along the releasing portion causes a sideway disposition of the free end and upon continuation of the movement of the secondary locking member (200; 200') in insertion direction, the free end will be freed out of engagement with the deflection surface, whereby the free end springs back in a direction opposing the insertion direction and is moved completely into the second position and when the secondary locking member (200; 200') is placed in the second position, the safety spring bar (400; 400') is adapted to snap into a safety position, to lock the secondary locking member (200; 200') in its second position wherein the free end is received in at least one notch of the secondary locking member (200; 200').
A pipe support structure comprising a support member fabricated from structural steel defining a support surface, and a plurality of pipe support elements fabricated from and/or coated with a corrosion-resistant material, in that the material is more corrosion-resistant than is the structural steel material of the support member; wherein the support surface defines a plurality of grooves in the support surface of the support member each correspondingly sized and shaped to receive a respective one of the pipe support elements, elements; with the pipe support element being sized to project beyond its groove when so received, each of the plurality of pipe support elements being respectively received in a complementary groove.
A working vehicle comprising: an upper exterior cover covering an upper side of an engine compartment housing an engine; an exhaust heat vent (24, 25, 27, 28, 29) provided to an upper surface (20B, 20C) of the upper exterior cover; an exhaust gas aftertreatment device configured to purify exhaust gas from the engine, characterized in that a gutter member (41, 42) is disposed below the exhaust heat vent (24, 25, 27, 28, 29), the gutter member (41, 42) having a lateral surface defining a rise portion rising from a bottom of the gutter member (41, 42), the rise portion being attached to the upper exterior cover, and the exhaust gas aftertreatment device is disposed above the engine and below the gutter member (41, 42) so that the exhaust gas aftertreatment device overlaps with the engine and the gutter member (41, 42) in a vehicle top-bottom direction. an upper exterior cover covering an upper side of an engine compartment housing an engine; an exhaust heat vent (24, 25, 27, 28, 29) provided to an upper surface (20B, 20C) of the upper exterior cover; an exhaust gas aftertreatment device configured to purify exhaust gas from the engine, characterized in that a gutter member (41, 42) is disposed below the exhaust heat vent (24, 25, 27, 28, 29), the gutter member (41, 42) having a lateral surface defining a rise portion rising from a bottom of the gutter member (41, 42), the rise portion being attached to the upper exterior cover, and the exhaust gas aftertreatment device is disposed above the engine and below the gutter member (41, 42) so that the exhaust gas aftertreatment device overlaps with the engine and the gutter member (41, 42) in a vehicle top-bottom direction.
A negative resist composition comprising an onium salt having the formula: wherein R 1 is a C 1 -C 20 monovalent hydrocarbon group which may contain a heteroatom, the ring R is a group having the formula, or a C 6 -C 30 group having an alicyclic structure in which some carbon may be replaced by a moiety containing sulfur, oxygen or nitrogen, wherein the broken line designates a valence bond, R 2 is each independently a C 1 -C 20 monovalent hydrocarbon group which may contain a heteroatom, n is an integer of 2 to 5, Z + is a sulfonium cation having the formula or iodonium cation having the formula: wherein R 3 to R 7 are each independently a C 1 -C 20 monovalent hydrocarbon group which may contain a heteroatom, any two or more of R 3, R 4 and R 5 may bond together to form a ring with the sulfur atom to which they are attached; and a base polymer containing a polymer comprising recurring units having the formula: wherein R A is hydrogen, fluorine, methyl or trifluoromethyl, R 11 is each independently halogen, an optionally halogenated C 2 -C 8 acyloxy group, optionally halogenated C 1 -C 6 alkyl group, or optionally halogenated C 1 -C 6 alkoxy group, A 1 is a single bond or C 1 -C 10 alkanediyl group in which an ether bond may intervene in a carbon-carbon bond, t 1 is 0 or 1, x 1 is an integer of 0 to 2, a is an integer satisfying 0 ≤ a ≤ 5+2x 1 -b, and b is an integer of 1 to 5.
An electrode for a lithium-ion battery comprising: a collector layer; and an electrode active material layer which is provided on at least one surface of the collector layer and includes an electrode active material, a binder resin, and a conductive auxiliary agent, wherein an interface resistance between the collector layer and the electrode active material layer, which is measured at a normal pressure by bringing an electrode probe into contact with a surface of the electrode active material layer in accordance with the measurement procedure as disclosed in the description, is more than 0.0010 Ω·cm 2 and less than 0.10 Ω·cm 2, characterized in that the electrode active material is a positive electrode active material. a collector layer; and an electrode active material layer which is provided on at least one surface of the collector layer and includes an electrode active material, a binder resin, and a conductive auxiliary agent, wherein an interface resistance between the collector layer and the electrode active material layer, which is measured at a normal pressure by bringing an electrode probe into contact with a surface of the electrode active material layer in accordance with the measurement procedure as disclosed in the description, is more than 0.0010 Ω·cm 2 and less than 0.10 Ω·cm 2, characterized in that the electrode active material is a positive electrode active material.
Benzamides of the formula or salts thereof where the symbols and indices are each defined as follows: Q is a Q1, Q2, Q3 or Q4 radical, X is (C 1 -C 6) -alkyl or (C 3 -C 6) -cycloalkyl, Z is (C 3 -C 6) -cycloalkyl, R is (C 1 -C 6) -alkyl, (C 3 -C 6) -cycloalkyl, (C 3 -C 6)-cycloalkyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkyl-O- (C 1 -C 6) -alkyl, R X is methyl, ethyl, n-propyl, prop-2-en-1-yl, methoxyethyl, ethoxyethyl or methoxyethoxyethyl, R Y is methyl, ethyl, n-propyl, chlorine or amino, R Z is methyl, ethyl, n-propyl or methoxymethyl, n is 0, 1 or 2. Q is a Q1, Q2, Q3 or Q4 radical, X is (C 1 -C 6) -alkyl or (C 3 -C 6) -cycloalkyl, Z is (C 3 -C 6) -cycloalkyl, R is (C 1 -C 6) -alkyl, (C 3 -C 6) -cycloalkyl, (C 3 -C 6)-cycloalkyl- (C 1 -C 6) -alkyl, (C 1 -C 6) -alkyl-O- (C 1 -C 6) -alkyl, R X is methyl, ethyl, n-propyl, prop-2-en-1-yl, methoxyethyl, ethoxyethyl or methoxyethoxyethyl, R Y is methyl, ethyl, n-propyl, chlorine or amino, R Z is methyl, ethyl, n-propyl or methoxymethyl, n is 0, 1 or 2.
An encoder device for determining an absolute position of a first object relative to a second object, comprising a dimensional scale connected to the first object and having an absolute code track of a plurality of code elements, a scanning device connected to the second object and having at least a first receiver and a second receiver for at least twice scanning the absolute code track, wherein the receivers (20a-b) are arranged offset from one another along the absolute code track by a fraction of the extent of a code element and each comprise a plurality of individual receiving elements in a row arrangement along the absolute code track for generating scanning signals of the code elements, and a control and evaluation unit configured to select, for a respective determination of an absolute position, the receiver (20a-b) which is aligned more favorably with respect to the absolute code track, and to reconstruct a code word from the scanning signals of the individual receiver elements of the selected receiver (20a-b) and thus to determine the absolute position, characterized in that the control and evaluation unit is further configured to determine in which receiver (20a-b) an individual receiving element scans a different code element than in a previous determination of the absolute position and to select the other receiver (20b-a) for the determination of the current absolute position.
A method of processing an amniotic membrane to provide a vacuum-dried amniotic membrane comprising vacuum-drying the amniotic membrane wherein the membrane is not frozen before the vacuum drying step, and wherein the membrane is treated with one or more lyoprotectants before vacuum-drying.
Cleaning capsule for lodging in the brew group of a hot drink system, in particular of a coffee machine, with a hollow space, which hollow space contains a cleaning agent, characterized in that the cleaning capsule contains in the hollow space a chemically inert filling agent additionally to the cleaning agent so that the hollow space is permanently filled with the filling agent, even during the cleaning process.
Die tooling for controlling the distribution of molten plastic between a die head and an extrusion outlet (6; 8) for forming continuous tubular plastic product, said die tooling constituting a one piece body member and comprising a series of individual passages (50, 52; 60, 62) drilled through a length of said body member with adjacent passages integrally connected by said body member and with spaced inlets to said passages (50, 52; 60, 62) at said die head for receiving molten plastic under pressure; said individual passages (50, 52; 60, 62) forming a predetermined pattern of non-circular passage outlets (64, 66; 52, 54) adjacent and upstream of said extrusion outlet (6; 8); and said extrusion outlet (6; 8) being defined between an interior wall and an exterior wall for extruding molten plastic forming said tubular plastic product; characterized in that with regard to the predetermined pattern of non-circular passage outlets (64, 66; 52, 54), said individual passages (50, 52; 60, 62) form an inner tubular elongate pattern having a generally flat base, opposed curved ends and a curved top, and form a corresponding outer tubular elongate pattern aligned about said inner tubular elongate pattern.
A population of hematopoietic stem and progenitor cells (HSPCs) for use in a method of treating cancer in a human subject, wherein the method comprises administering to said human subject: a) the population of HSPCs; b) a population of cells comprising fresh regulatory T cells (Tregs); c) a population of conventional T cells (Tcons); and d) a graft versus host disease (GVHD) prophylactic agent; wherein said population of HSPCs and said population of cells comprising fresh Tregs are administered prior to said population of Tcons; wherein said population of cells comprising fresh Tregs has not been cryopreserved prior to said administering of said population of cells comprising fresh Tregs; and wherein said GVHD prophylactic agent is tacrolimus or sirolimus; and wherein said human subject does not develop graft versus host disease (GVHD) within 30 days of said administering of said population of Tcons. a) the population of HSPCs; b) a population of cells comprising fresh regulatory T cells (Tregs); c) a population of conventional T cells (Tcons); and d) a graft versus host disease (GVHD) prophylactic agent; wherein said population of HSPCs and said population of cells comprising fresh Tregs are administered prior to said population of Tcons; wherein said population of cells comprising fresh Tregs has not been cryopreserved prior to said administering of said population of cells comprising fresh Tregs; and wherein said GVHD prophylactic agent is tacrolimus or sirolimus; and wherein said human subject does not develop graft versus host disease (GVHD) within 30 days of said administering of said population of Tcons.
A system for facilitating deployment of an endoluminal prosthesis (110, 210), including: a main tubular graft body of a biocompatible material including a proximal end (118, 218) opening, a distal end (119, 219) opening, a lumen (120, 220) extending longitudinally between the proximal end (118, 218) opening and the distal end (119, 219) opening, and a sidewall; a branch (130, 140, 230, 240) extending from the sidewall and including a first end opening, a second end opening, and a lumen (135, 145, 235, 245) extending between the first end opening and the second end opening of the branch; a fenestration (150, 250) in the sidewall positioned distal of the second end opening of the branch; and a wire segment including a proximal portion positioned proximal of the proximal end opening and a distal portion positioned distal of the distal end opening, the wire segment extending through the fenestration (150, 250) and through the lumen of the branch (130, 140, 230, 240) in a preloaded configuration, the wire segment extending through both the proximal end (118, 218) opening and the distal end (119, 219) opening, the branch and/or fenestration being for receiving a side branch prosthesis. a main tubular graft body of a biocompatible material including a proximal end (118, 218) opening, a distal end (119, 219) opening, a lumen (120, 220) extending longitudinally between the proximal end (118, 218) opening and the distal end (119, 219) opening, and a sidewall; a branch (130, 140, 230, 240) extending from the sidewall and including a first end opening, a second end opening, and a lumen (135, 145, 235, 245) extending between the first end opening and the second end opening of the branch; a fenestration (150, 250) in the sidewall positioned distal of the second end opening of the branch; and a wire segment including a proximal portion positioned proximal of the proximal end opening and a distal portion positioned distal of the distal end opening, the wire segment extending through the fenestration (150, 250) and through the lumen of the branch (130, 140, 230, 240) in a preloaded configuration, the wire segment extending through both the proximal end (118, 218) opening and the distal end (119, 219) opening, the branch and/or fenestration being for receiving a side branch prosthesis.
A method of expanding human hepatocytes in vivo, comprising: i) transplanting isolated human hepatocytes into a Rag2 - / - / Il2rg -l- mouse, wherein the mouse is deficient for expression of Fah; ii) allowing the human hepatocytes to expand for at leasttwo weeks; and iii) collecting human hepatocytes from the mouse, wherein the mouse is homozygous for deletions or one or more point mutations in the Fah gene. i) transplanting isolated human hepatocytes into a Rag2 - / - / Il2rg -l- mouse, wherein the mouse is deficient for expression of Fah; ii) allowing the human hepatocytes to expand for at leasttwo weeks; and iii) collecting human hepatocytes from the mouse, wherein the mouse is homozygous for deletions or one or more point mutations in the Fah gene.
A device for monitoring an anchor for anchoring a water vessel, the device comprising: an accelerometer configured to measure acceleration of the device to yield acceleration data; and means configured to process the acceleration data to yield velocity data, characterized by: means configured to process the acceleration data to yield roll angle data, the roll angle data indicating a roll angle of the anchor; and means (52, 54) configured to transmit the roll angle data and the velocity data from the device to a receiver unit for use with the water vessel. an accelerometer configured to measure acceleration of the device to yield acceleration data; and means configured to process the acceleration data to yield velocity data, characterized by: means configured to process the acceleration data to yield roll angle data, the roll angle data indicating a roll angle of the anchor; and means (52, 54) configured to transmit the roll angle data and the velocity data from the device to a receiver unit for use with the water vessel. means configured to process the acceleration data to yield roll angle data, the roll angle data indicating a roll angle of the anchor; and means (52, 54) configured to transmit the roll angle data and the velocity data from the device to a receiver unit for use with the water vessel.
Use of 1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1 H-imidazol-2-one or a physiologically acceptable salt thereof as an active ingredient for the manufacture of a medicament for the treatment of behavioral abnormalities, which is anxiety, in dogs.
Device for the medical care of a patient in an emergency which comprises: an item of clothing which may be worn by the patient on the body a monitoring device (8, 9) arranged on the item of clothing which may monitor at least one physiological function of the patient in order to determine an emergency; and a respiratory therapeutic device (10, 11, 12, 13) which may supply oxygen, an oxygen-containing gas mixture and/or at least one drug endotracheally, characterised in that the respiratory therapeutic device is arranged on the item of clothing, and the respiratory therapeutic device (10, 11, 12, 13) comprises a puncture unit arranged in the item of clothing and adopted to perforate the trachea of the patient wearing the item of clothing below the larynx, which puncture unit is operatively connected to the monitoring device (8, 9) such that the monitoring device (8, 9) triggers the perforation when it determines an emergency. an item of clothing which may be worn by the patient on the body a monitoring device (8, 9) arranged on the item of clothing which may monitor at least one physiological function of the patient in order to determine an emergency; and a respiratory therapeutic device (10, 11, 12, 13) which may supply oxygen, an oxygen-containing gas mixture and/or at least one drug endotracheally, characterised in that the respiratory therapeutic device is arranged on the item of clothing, and the respiratory therapeutic device (10, 11, 12, 13) comprises a puncture unit arranged in the item of clothing and adopted to perforate the trachea of the patient wearing the item of clothing below the larynx, which puncture unit is operatively connected to the monitoring device (8, 9) such that the monitoring device (8, 9) triggers the perforation when it determines an emergency.
A method for orienting a view of a 3D scene within a map viewport (100A, 100B, 100C) displayed on a client computing device, the method comprising: receiving 3D data representative of a 3D scene via a computer network, the scene including a map feature and a zoom level; identifying a 3D geometry of the map feature within the 3D scene based on the received 3D data; determining a point within the 3D geometry of the map feature based on a location of a 3D cursor within the 3D scene; characterised in that, the method further comprises the steps of: determining an approximate normal to a surface of the map feature, wherein the approximate normal is proximate to the determined point within the 3D geometry; determining an orientation of the 3D cursor based on the determined approximate normal to the map feature surface; orienting the 3D cursor, within the displayed map viewport, according to the determined orientation to indicate to a user the surface of the map feature that will be displayed in the map viewport in response to a selection of the 3D cursor, wherein orienting the 3D cursor comprises displaying an arrow portion to indicate the determined orientation of the 3D cursor; receiving a selection of the 3D cursor while the 3D cursor is oriented according to the determined orientation; and rotating the 3D scene view in response to receiving the selection of the 3D cursor to display the view of the map feature surface indicated by the 3D cursor orientation. receiving 3D data representative of a 3D scene via a computer network, the scene including a map feature and a zoom level; identifying a 3D geometry of the map feature within the 3D scene based on the received 3D data; determining a point within the 3D geometry of the map feature based on a location of a 3D cursor within the 3D scene; determining an approximate normal to a surface of the map feature, wherein the approximate normal is proximate to the determined point within the 3D geometry; determining an orientation of the 3D cursor based on the determined approximate normal to the map feature surface; orienting the 3D cursor, within the displayed map viewport, according to the determined orientation to indicate to a user the surface of the map feature that will be displayed in the map viewport in response to a selection of the 3D cursor, wherein orienting the 3D cursor comprises displaying an arrow portion to indicate the determined orientation of the 3D cursor; receiving a selection of the 3D cursor while the 3D cursor is oriented according to the determined orientation; and rotating the 3D scene view in response to receiving the selection of the 3D cursor to display the view of the map feature surface indicated by the 3D cursor orientation.
Device for controlling the position of a control lever on the external control unit of a gearbox, said device being composed of two parts: - a first part, called a "positioning body", which comprises a surface for controlled holding of the control lever and means for anchoring said positioning body on the external control unit, and - a second part, called a "locking body", which is intended to be mounted on the positioning body with a locking position and an unlocking position, said locking body comprising means for locking the anchoring means of the positioning body on the external control box, and anchoring means of the locking body on the positioning body, said device being characterized in that the means for anchoring the positioning body on the external control box are constituted by a plurality of "clipping" pins, each clipping pin having the shape of a cylindrical sleeve with an external bulge at its lower part, which forms a clip and is intended to immobilize the clipping pin on a corresponding shoulder of the external control. - a first part, called a "positioning body", which comprises a surface for controlled holding of the control lever and means for anchoring said positioning body on the external control unit, and - a second part, called a "locking body", which is intended to be mounted on the positioning body with a locking position and an unlocking position, said locking body comprising means for locking the anchoring means of the positioning body on the external control box, and anchoring means of the locking body on the positioning body,